Listed

Champions Oncology, Inc.: Form 10-K for the period ended Apr 30, 2020

Filed with the SEC on Jul 28, 2020 and accepted by EDGAR at Jul 28, 2020, 17:29 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-04-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2019-05-01 to 2020-04-30$32.1mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Research and development12 months2019-05-01 to 2020-04-30$5.9mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2019-05-01 to 2020-04-30−$1.8mus-gaap:OperatingIncomeLoss
Income tax12 months2019-05-01 to 2020-04-30$130.0kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2019-05-01 to 2020-04-30−$2.0mus-gaap:NetIncomeLoss
Diluted EPS12 months2019-05-01 to 2020-04-30−$0.17us-gaap:EarningsPerShareDiluted
Basic EPS12 months2019-05-01 to 2020-04-30−$0.17us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2019-05-01 to 2020-04-3011,843,463 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2019-05-01 to 2020-04-30$2.9mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2019-05-01 to 2020-04-30$2.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Current assetsAt period end2020-04-30$13.5mus-gaap:AssetsCurrent
Total assetsAt period end2020-04-30$20.8mus-gaap:Assets
Current liabilitiesAt period end2020-04-30$12.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-04-30$15.4mus-gaap:Liabilities
Shareholders' equityAt period end2020-04-30$5.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001628280-20-010734. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.